Smoking marijuana (cannabis) does not increase the user’s risk of head and neck cancer, according to a new study published in the March 2008 issue of Otolaryngology – Head and Neck Surgery.
The small sample study, authored by researchers from New Zealand and Great Britain, found that among 75 cases of head and neck cancer, the relative risk of smoking cannabis and contracting head and neck cancer in marijuana users was the same (1.0) as in those who had never smoked cannabis. These results differ from the relative risk of contracting cancer from smoking cigarettes (2.1) and the heavy consumption of alcohol (5.7), compared with those who abstained from those activities.
However, due to the limits of the study, the authors cannot exclude other possible effects, and recommend a larger study.
Cancers of the head and neck, with more than 500,000 new cases diagnosed each year worldwide, represent the fourth most common type of cancer. It is estimated that more than 13,000 people will die from head and next cancer each year in the United States alone.
Source: American Academy of Otolaryngology, Head and Neck Surgery
Related stories:
Blood vessel inhibitor shows promise against metastatic thyroid cancer
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of
The New England Journal of Medicine.
Effects of healing touch therapy being studied
Often, a gentle hand on your shoulder when you're upset is all it takes to ease your mind and calm your nerves. Now, University of Cincinnati (UC) researchers are looking at a similar occurrence by pairing a complementary therapy known as Healing Touch with mild sedation to see if the technique truly calms patients undergoing minor procedures.
Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show
(Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.
Combining radiation and surgery significantly improves survival for head and neck cancer patients
Adding radiation therapy to surgery significantly improves overall survival in patients diagnosed with node-positive head and neck cancer when compared to treating with surgery alone, according to a study in the June issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Acupuncture reduces pain and dysfunction in head and neck cancer patients after neck dissection
New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection. The study was led by David Pfister, MD, Chief of the Head and Neck Medical Oncology Service, and Barrie Cassileth, PhD, Chief of the Integrative Medicine Service, at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr. Pfister presented the findings today at the annual meeting of the American Society for Clinical Oncology.
Quality of life predicts cancer survival
Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center. The findings could mean that identifying patients with poor quality of life could also identify patients with particularly aggressive tumors.
Fruits, vegetables and teas may protect smokers from lung cancer
Tobacco smokers who eat three servings of fruits and vegetables per day and drink green or black tea may be protecting themselves from lung cancer, according to a first-of-its-kind study by UCLA cancer researchers.
Gene therapy increases survival for end-stage head and neck cancer
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.